GSK961081 Alone and With Fluticasone Furoate (FF), Phase 1 (Ph1), Single Dose Regimen (SD), Repeat Dose Regimen (RD), Pharmacokinetic (PK) Study in Healthy Volunteer (HV)

NCT02666287 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: BAT/FF
DRUG: BAT
DRUG: FF
DRUG: FF (MgSt)
DRUG: FF/Vilanterol

Sponsor

GlaxoSmithKline

Collaborators

[object Object]